Atrial fibrillation increases thrombogenicity of LVAD therapy.
Venkat Keshav ChivukulaJennifer BeckmanSong LiNazem AkoumAlberto AlisedaClaudius MahrPublished in: The International journal of artificial organs (2024)
This supports the hypothesis that AF results in unfavorable blood flow patterns in the LV adding to an increased stroke risk for LVAD + AF patients. Quantification of thrombogenic risk associated with AF for LVAD patients may help guide clinical decision-making on interventions to mitigate the increased risk of thromboembolic events.
Keyphrases
- atrial fibrillation
- end stage renal disease
- blood flow
- ejection fraction
- newly diagnosed
- chronic kidney disease
- decision making
- heart failure
- physical activity
- left atrial
- peritoneal dialysis
- left atrial appendage
- catheter ablation
- oral anticoagulants
- direct oral anticoagulants
- mesenchymal stem cells
- cell therapy
- left ventricular
- replacement therapy